Page 5 - Serum Institute Of India

India at 75: Tatas to Naik, Murthy - 25 towering business leaders of India

Some are 'Midnight's Children' whose pre-Independence businesses bloomed after 1947, some 'Licence Raj Warriors' who refused to let red-tapeism slow them down. A look at 25 towering business leaders

Serum Institute explores new-age vaccine delivery systems for growth

The Pune-based company that manufactured the Covid-19 vaccine administered to most Indians is exploring more sophisticated delivery systems

TMS Ep230: Startups, Adar Poonawalla, Indian rupee, Encumbrance Certificate

Are Indian start-ups on a road to profitability? What is keeping Adar Poonawalla busy these days? Is the current strength in rupee sustainable? What is an Encumbrance Certificate? All answers here

What is keeping Adar Poonawalla busy these days?

Adar Poonawalla has taken Indian vaccines to the US and European markets. In an interview with Business Standard's Sohini Das, he tells about his plans for mass production of vaccines and more

We've demonstrated our quality & capability to enter US, Europe: SII CEO

80-90% of our global capacity will be in India, says SII CEO Adar Poonawalla

Top Headlines: Windfall tax revision, Jio's purchase of 700 MHz, and more

The government on late Tuesday increased the windfall tax on domestically produced crude to Rs 17,750 a tonne from Rs 17,000 a tonne earlier

Serum Institute plans pandemic facility to stockpile vax for the world

Adar Poonawalla, CEO and brain behind the new age SII, says in an interaction with Business Standard that by the end of 2021, the company was making 250 million doses a month

SII conducting research to find monkeypox vaccine: CEO Adar Poonawalla

Poonawalla is learnt to have briefed Union Health Minister Mansukh Mandaviya on the subject during a meeting at the Nirman Bhawan here on Tuesday.

Mylab, firm that makes kits to detect Covid, starts pathology test facility

"We are now getting to 'wet' pathology tests like blood tests etc and we have set up a centre which will have minimal human intervention and maximum automation

Serum Institute in talks with Danish firm to import monkeypox vaccine

India has reported four cases monkeypox, including three in Kerala, so far

DCGI approves India's first qHPV vaccine to treat cervical cancer

SII's CEO Adar Poonawalla tweeted to make the announcement, 'For the first time, there will be an Indian HPV vaccine to treat cervical cancer in women that is both affordable and accessible'

SII gets govt nod to export 3.24 mn doses of Covovax vaccine to US

COVID-19 jab Covovax will be the first vaccine to be exported to the country, under the brand name Nuvaxovid, by any Indian manufacturer, official sources said on Friday

SII's Covovax gets DCGI's nod for emergency use in children aged 7-11 yrs

The DCGI's nod came after the subject expert committee on COVID-19 of the CSDCO last week recommended granting emergency use authorisation to Covovax for the age group of 7 to 11 years

Expert panel approves use of Serum Institute's Covovax for 7-11-year olds

India started vaccinating adolescents (aged 15-18) from January, and further expanded the drive to include children as young as 12 years from March

DCGI panel to review on Friday SII applications for Covovax use among kids

The expert panel in its last meeting in April had sought more data from SII following its application seeking the emergency use authorization of Covovax for seven to 11 years

Hundreds of millions of Covid vaccines in India to expire in September

Covaxin has a shelf life of 12 months, while Covishield, the vaccine that accounted for nearly 80% of India's vaccinations, has a shelf life of nine months

India's Serum Institute to make Novavax's Covid vaccine for US market

The company has indicated in the first quarter earnings call that it has reached a major milestone in its pathway to an emergency use authorisation from the US Food and Drugs Administration

Covid vaccine for US to be manufactured by India's Serum, says Novavax

Novavax Inc said on Tuesday that its Covid-19 vaccine initially available in the United States, if authorized, will be manufactured by the Serum Institute of India.

Covid-19 vaccine: SII to test Novavax for Omicron variant strain

The Pune-based company has also got a nod from the Indian drug regulator's office to manufacture trial batches of this vaccine for the purpose of testing, sources indicated.

Serum Institute likely to launch cervical cancer vaccine in India in Nov

Country now depends on foreign companies and Serum's product is likely to bring down prices.